<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="iso-abbrev">Mol. Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26730174</article-id><article-id pub-id-type="pmc">4688417</article-id><article-id pub-id-type="publisher-id">119</article-id><article-id pub-id-type="publisher-manuscript">2015MOLVIS0453</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Mei</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China</aff><aff id="aff2"><label>2</label>Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Qi Mei, Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China; Phone: +86-027-83663407; FAX: +86-027-83662834; email: <email xlink:href="borismq@163.com">borismq@163.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>14</day><month>12</month><year>2015</year></pub-date><volume>21</volume><fpage>1307</fpage><lpage>1317</lpage><history><date date-type="received"><day>22</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 Molecular Vision.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>Retinoblastoma (RB) is a common pediatric cancer. The study aimed to uncover the mechanisms of RB progression and identify novel therapeutic biomarkers.</p></sec><sec><title>Methods</title><p>The miRNA expression profile GSE7072, which includes three RB samples and three healthy retina samples, was used. After data normalization using the preprocessCore package, differentially expressed miRNAs (DE-miRs) were selected by the limma package. The targets of the DE-miRs were predicted based on two databases, followed by construction of the miRNA&#x02013;target network. Pathway enrichment analysis was conducted for the targets of the DE-miRNAs using DAVID. The CTD database was used to predict RB-related genes, followed by clustering analysis using the pvclust package. The correlation network of DE-miRs was established. MiRNA expression was validated in another data set, GSE41321.</p></sec><sec><title>Results</title><p>In total, 24 DE-miRs were identified whose targets were correlated with the cell cycle pathway. Among them, <italic>hsa-miR-373</italic>, <italic>hsa-miR-125b</italic>, and <italic>hsa-miR-181a</italic> were highlighted in the miRNA&#x02013;target regulatory network; 14 DE-miRs, including <italic>hsa-miR-373</italic>, <italic>hsa-miR-125b</italic>, <italic>hsa-miR-18a</italic>, <italic>hsa-miR-25</italic>, <italic>hsa-miR-20a</italic>, and <italic>hsa-let-7</italic> (<italic>a, b, c</italic>), were shown to distinguish RB from healthy tissue. In addition, <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-miR-20a</italic> shared the common target <italic>BCL2L11</italic>; <italic>hsa-let-7b</italic> and <italic>hsa-miR-125b</italic> targeted the genes <italic>CDC25A</italic>, <italic>CDK6</italic>, and <italic>LIN28A</italic>. Expression of three miRNAs in GSE41321 was consistent with that in GSE7072.</p></sec><sec><title>Conclusions</title><p>Several critical miRNAs were identified in RB progression. <italic>Hsa-miR-373</italic> might regulate RB invasion and metastasis, <italic>hsa-miR-181a</italic> might involve in the <italic>CDKN1B</italic>-mediated cell cycle pathway, and <italic>hsa-miR-125b</italic> and <italic>hsa-let-7b</italic> might serve as tumor suppressors by coregulating <italic>CDK6</italic>, <italic>CDC25A</italic>, and <italic>LIN28A</italic>. The miRNAs <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-miR-20a</italic> might exert their function by coregulating <italic>BCL2L1</italic>.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Retinoblastoma (RB) is the most common pediatric malignancy. The epidemiology of RB has been investigated in many population-based studies, and the incidence rate of RB is estimated at 40&#x02013;60 cases per million live births in the world [<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r4" ref-type="bibr">4</xref>]. Although the mortality rate is low in patients with RB who receive aggressive multimodal therapy, in developed countries, nearly half of patients with advanced bilateral RB suffer from partial or full sight loss [<xref rid="r5" ref-type="bibr">5</xref>]. In developing countries, because the disease is often diagnosed at later stages, the survival rate is lower than in developed countries [<xref rid="r6" ref-type="bibr">6</xref>].</p><p>To reduce morbidity and preserve the sight of a child during the early stages of RB, numerous studies have explored more effective approaches, such as targeted therapy using bioinformatics methods. For instance, combining epigenetic analysis with gene expression analysis, Zhang et al. identified the important oncogene <italic>spleen tyrosine kinase (SYK;</italic> Gene ID: 6850; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=600085">600085</ext-link>), which is elevated in RB and essential for RB tumor cell survival [<xref rid="r7" ref-type="bibr">7</xref>]. Another study also discovered 119 candidate genes, such as <italic>CDC25C</italic> (Gene ID: 995, OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=157680">157680</ext-link>), <italic>CDC6</italic> (Gene ID: 990, OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=602627">602627</ext-link>), and <italic>TP53</italic> (Gene ID: 7157 OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=191170">191170</ext-link>), for RB diagnosis [<xref rid="r8" ref-type="bibr">8</xref>]. MicroRNAs (miRNAs) are small noncoding RNAs that play significant roles in cellular functions and physiology. By regulating the expression of the target genes, miRNAs are confirmed to be involved in the development of various cancers, and thus have been suggested as tumor biomarkers [<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>]. Several miRNAs such as <italic>miR-30</italic>, <italic>miR-let-7e</italic>, <italic>miR-21</italic>, and <italic>miR-320</italic> are dysregulated in RB samples and have been supposed to be diagnostic biomarkers for detecting RB [<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]. Downregulated <italic>miR-204</italic> is another indicator in RB prediction [<xref rid="r13" ref-type="bibr">13</xref>]. Martin et al., using a TaqMan Low Density Array, discovered a total of 41 differentially expressed miRNAs (DE-miRs) between 12 RB samples and three healthy retina samples in humans, including 13 previously identified miRNAs (<italic>miR-17</italic>, <italic>miR-20b</italic>, <italic>miR-22</italic>, <italic>miR-25</italic>, <italic>miR-34a</italic>, <italic>miR-34c-5p</italic>, <italic>miR-106a</italic>, <italic>miR-106b</italic>, <italic>miR-93</italic>, <italic>miR-129</italic>, <italic>miR-193&#x02013;5p</italic>, <italic>miR-342&#x02013;5p</italic>, <italic>miR-370</italic>) in human and mouse RB and many novel miRNAs, such as <italic>miR-18a</italic>, <italic>miR-138</italic>, <italic>miR-155</italic>, <italic>miR-382</italic>, and <italic>miR-504</italic> [<xref rid="r14" ref-type="bibr">14</xref>]. Additionally, the <italic>miR-17&#x02013;92</italic> cluster has been demonstrated as an RB-collaborating gene that promotes RB development [<xref rid="r15" ref-type="bibr">15</xref>]. More recently, another 18 miRNAs have been newly implicated in RB and have great potential to serve as signatures in the detection of this disease [<xref rid="r16" ref-type="bibr">16</xref>]. However, the target genes of these miRNAs are rarely reported. Notably, using paired mRNA and miRNA expression profiles, Huang et al. identified several targets of miRNAs in RB samples and further verified <italic>CDC25A</italic> (Gene ID: 993 OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=116947">116947</ext-link>) and <italic>BCL7A</italic> (Gene ID: 605 OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=601406">601406</ext-link>) are the target genes of <italic>let-7b</italic> [<xref rid="r17" ref-type="bibr">17</xref>]. However, the researchers emphasized the roles of miRNA <italic>let-7b</italic> and did not mention other potential miRNAs or the correlations between them. In addition, the detailed regulation mechanisms of miRNAs to RB remain obscure.</p><p>Therefore, we reanalyzed the miRNA expression profile GSE7072 [<xref rid="r17" ref-type="bibr">17</xref>] to obtain more relevant miRNAs using differential analysis. The targets of these miRNAs were also predicted using two experimental validated databases (miRecords and MirWalk). Relationships between these miRNAs were further explored to comprehensively uncover the underlying mechanisms of RB progression. We aimed to find novel miRNA biomarkers for the prevention and prognosis of RB development.</p></sec><sec sec-type="methods"><title>Methods</title><p>A flowchart of the analyses in the study is shown in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Flowchart of the analyses.</p></caption><graphic xlink:href="mv-v21-1307-f1"/></fig><sec><title>Microarray data</title><p>The miRNA expression profile data with the accession number GSE7072 [<xref rid="r17" ref-type="bibr">17</xref>], which is available in the public Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">GEO</ext-link>) database, was employed in the present study. The data set comprised the total RNA information of a cohort of 160 human miRNAs from three RB samples and three replicates of a healthy retina, based on the platform of the GPL4879Human miRNA 2k custom array (Agilent Technologies, Palo Alto, CA). The annotation files on the platform were downloaded.</p></sec><sec><title>Data preprocessing and identification of DE-miRs</title><p>Based on the annotation information, the probe levels were converted into miRNA expression values. The probe that did not correspond to a specific miRNA was removed, and when more than one probe corresponded to a single miRNA, the average value at the probe level was calculated as the final expression value of this miRNA. Then the data were subjected to normalization using the median method in the <ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/packages/2.4/bioc/html/preprocessCore.html">preprocessCore</ext-link> package [<xref rid="r18" ref-type="bibr">18</xref>]. Afterwards, the DE-miRs between the RB and healthy retina samples were selected using the limma (<ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/packages/release/bioc/html/limma.html">Linear Models for Microarray Analysis</ext-link>) package of R [<xref rid="r19" ref-type="bibr">19</xref>]. The cut-off values for significant DE-miRs were p&#x0003c;0.05 and |log<sub>2</sub> (fold change)| &#x0003e;0.58.</p></sec><sec><title>Construction of integrated miRNA&#x02013;target network</title><p>Considering that a miRNA works through the regulation of the target in a spectrum of biologic processes, we further explored the potential target genes of these identified DE-miRs, by integrating the information in two experimentally validated databases, the <ext-link ext-link-type="uri" xlink:href="http://c1.accurascience.com/miRecords/">miRecords</ext-link> [<xref rid="r20" ref-type="bibr">20</xref>] and <ext-link ext-link-type="uri" xlink:href="http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/">MirWalk</ext-link> [<xref rid="r21" ref-type="bibr">21</xref>], in which miRNA&#x02013;target interactions were experimentally validated. Only the miRNA&#x02013;target interaction that existed in at least one of the two databases was screened out to establish the integrated miRNA&#x02013;target network.</p></sec><sec><title>Pathway enrichment analysis of the predicted target genes</title><p>To further identify the altered biologic pathways of the target genes, the Kyoto Encyclopedia of Genes and Genomes (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/kegg/pathway.html">KEGG</ext-link>) pathway enrichment analysis was conducted with the Database for Annotation, Visualization and Integration Discovery (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.Ncifcrf.gov/">DAVID</ext-link>) software [<xref rid="r22" ref-type="bibr">22</xref>], based on the hypergeometric distribution. p&#x0003c;0.05 was set as the threshold for the selection of significant pathways.</p></sec><sec><title>Identification of transcription factors, tumor-associated genes, and tumor suppressor genes</title><p>The target genes were mapped into the <ext-link ext-link-type="uri" xlink:href="http://www.biobase-international.com/gene-regulation">TRASFAC</ext-link> database [<xref rid="r23" ref-type="bibr">23</xref>] to further screen the potential transcription factors (TFs). Meanwhile, by comparing these targets with the information from the tumor suppressor gene (TSG) [<xref rid="r24" ref-type="bibr">24</xref>] and tumor-associated gene (<ext-link ext-link-type="uri" xlink:href="http://www.binfo.ncku.edu.tw/TAG/">TAG</ext-link>) databases, all known oncogenes and TSGs among the target genes were extracted.</p></sec><sec><title>Prediction of RB-related genes among the target genes</title><p>The target genes were mapped into the publicly available Comparative Toxicogenomics Database (<ext-link ext-link-type="uri" xlink:href="http://ctdbase.org">CTD</ext-link>) database, which provides curated chemical- and gene-disease interactions from published articles [<xref rid="r25" ref-type="bibr">25</xref>], to search the RB-related genes among these target genes. Then combined with the corresponding miRNAs, clustering analysis was performed between the RB and healthy retina samples with the <ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/">pvclust package</ext-link> of R [<xref rid="r26" ref-type="bibr">26</xref>].</p></sec><sec><title>Correlation network construction of the identified DE-miRs</title><p>Among the DE-miRs, two miRNAs that share a common target gene were filtered out to build the correlation network.</p></sec><sec><title>Validation of miRNA expression with another data set</title><p>Another RB-related miRNA expression profile, GSE41321 [<xref rid="r27" ref-type="bibr">27</xref>], which also contained three RB samples and three healthy samples, was downloaded in the GEO database and used to check whether the DE-miRs identified in this profile were consistent with those in the GSE7072 data set. Samples in the GSE41321 profile were collected from pooled serum from children with advanced RB and healthy age-matched children. Likewise, after expression value conversion from probe level to gene level, normalization was performed for data using the median method in the preprocessCore package [<xref rid="r18" ref-type="bibr">18</xref>]. Then the miRNA expression value was attained. The <ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/">CONOR</ext-link> package [<xref rid="r28" ref-type="bibr">28</xref>] was used to perform cross-platform normalization for the GSE7072 and GSE41321 data sets. DE-miRs between the RB and control samples were identified in the two data sets, respectively, using the limma package with the same threshold. Thereafter, we compared the miRNA expression in the two data sets, especially the 24 DE-miRs identified in GSE7072.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>The DE-miRs between the RB and healthy retina samples</title><p>As a result, a set of 24 DE-miRs were selected, including nine upregulated (e.g., <italic>hsa-miR-25</italic>, <italic>hsa-miR-373</italic>, and <italic>hsa-miR-20a</italic>) and 15 downregulated miRNAs (e.g., <italic>let-7b</italic>, <italic>let-7a</italic>, <italic>let-7c</italic>, <italic>hsa-miR-125b</italic>, and <italic>hsa-miR-181a</italic>) between the RB and healthy retina samples. The clustering analysis of the heat map is presented in <xref ref-type="fig" rid="f2">Figure 2</xref>, revealing the expression pattern of the DE-miRs.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Heat map of the clustering analysis of differentially expressed miRNAs between two samples. The x-axis represents the samples (healthy 1&#x02013;3 denote healthy retina samples, and Rb 1&#x02013;3 denote retinoblastoma samples), and the y-axis represents miRNAs.</p></caption><graphic xlink:href="mv-v21-1307-f2"/></fig></sec><sec><title>The integrated miRNA&#x02013;target regulatory network</title><p>Based on the criterion, the integrated miRNA&#x02013;target regulatory network was built, containing five upregulated miRNAs, including <italic>hsa-miR-373</italic> (the most prominent one with 53 target genes), <italic>hsa-miR-20a</italic> (with nine target genes), <italic>hsa-miR-18a</italic>, <italic>hsa-miR-25</italic>, and <italic>hsa-miR-175p</italic>, and 12 downregulated miRNAs, such as <italic>hsa-miR-125b</italic> (the most remarkable one with 54 target genes), <italic>hsa-miR-7</italic> (<italic>a, b, c</italic>), and <italic>hsa-miR-145</italic> (<xref ref-type="fig" rid="f3">Figure 3</xref>). Notably, <italic>hsa-miR-20a</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-miR-25</italic> shared the common target gene <italic>BCL2L11</italic>; <italic>hsa-miR-125b</italic>, <italic>hsa-miR-7a</italic>, and <italic>hsa-miR-7b</italic> cotargeted the gene <italic>LIN28A</italic>.</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Integrated miRNA&#x02013;target regulatory network. The blue circle represents genes, and the red rectangle represents upregulated miRNAs, while the green rectangle represents downregulated miRNAs. Arrows denote direct interactions between a miRNA and its target gene.</p></caption><graphic xlink:href="mv-v21-1307-f3"/></fig></sec><sec><title>Dysregulated pathways of the target genes</title><p>After the target genes were mapped into the KEGG databases, the altered pathways were identified. As shown in <xref ref-type="table" rid="t1">Table 1</xref>, the target genes of the upregulated miRNAs were significantly enriched in numerous cancer-related pathways such as pathways in cancer (hsa05200), bladder cancer (hsa05219), non-small cell lung cancer (hsa05223), and pancreatic cancer (hsa05212). The over-represented pathways for the targets of the downregulated miRNAs were also significantly correlated with various cancers, as well as the ErbB signaling pathway (hsa04012) and the cell cycle pathway (hsa04110).</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Significantly enriched pathways among the target genes of the differentially expressed miRNAs.</title></caption><table frame="hsides" rules="groups"><col width="212" span="1"/><col width="205" span="1"/><col width="85" span="1"/><col width="106" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Target genes</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Pathway Term</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Count</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>P value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Target genes of upregulated miRNAs<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05200:Pathways in cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">6<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3.62E-04<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05219:Bladder cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3.49 E-03<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05223:Non-small cell lung cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">5.73 E-03<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05212:Pancreatic cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">1.00 E-02<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05220:Chronic myeloid leukemia<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">1.08 E-02<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Target genes of downregulated miRNAs<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05219:Bladder cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">2.93E-10<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05200:Pathways in cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">19<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">2.71E-09<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05220:Chronic myeloid leukemia<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">11<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3.75E-09<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05214:Glioma<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">1.31E-08<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05215:Prostate cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">11<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">2.06E-08<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05218:Melanoma<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">3.87E-08<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05223:Non-small cell lung cancer<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">9<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">6.76E-08<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa04012:ErbB signaling pathway<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">9<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">2.91E-06<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">hsa04110:Cell cycle<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">5.14E-06<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="middle" align="left" rowspan="1" colspan="1">hsa05212:Pancreatic cancer</td><td valign="middle" align="left" rowspan="1" colspan="1">8</td><td valign="middle" align="left" rowspan="1" colspan="1">8.85E-06</td></tr></tbody></table><table-wrap-foot><p>Count, the gene numbers enriched in a specific pathway.</p></table-wrap-foot></table-wrap></sec><sec><title>Identified TFs, TAGs, and TSGs among target genes</title><p>As expected, the potential TFs, oncogenes, and TSGs were selected by comparing the targets with the information in relevant databases. Detailed gene information is presented in <xref ref-type="table" rid="t2">Table 2</xref>, in which target genes such as <italic>CBFB</italic> (Gene ID: 865; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=121360">121360</ext-link>), <italic>CEBPG</italic> (Gene ID: 1054; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=138972">138972</ext-link>), and <italic>HMGA2</italic> (Gene ID: 8091; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=600698">600698</ext-link>) were considered TFs; <italic>CCNA2</italic> (Gene ID: 890; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=123835">123835</ext-link>), <italic>CCND1</italic> (Gene ID: 595; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=168461">168461</ext-link>), and <italic>ERBB2</italic> (Gene ID: 2064; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=164870">164870</ext-link>) were oncogenes; and <italic>CDKN1B</italic> (Gene ID: 1027; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=600778">600778</ext-link>), <italic>CDKN2A</italic> (Gene ID: 1029; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=600160">600160</ext-link>), and <italic>E2F1</italic> (Gene ID: 1869; OMIM: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim/?term=189971">189971</ext-link>) were TSGs.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Predicted TFs, oncogenes and TSGs among the target genes of the differentially expressed miRNAs.</title></caption><table frame="hsides" rules="groups"><col width="137" span="1"/><col width="152" span="1"/><col width="135" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>TF</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Oncogene</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>TSG</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">CBFB,CEBPG,HMGA2,HOXA11,ID1,ID2,ID3,MEF2D,MITF,PLAGL1,PRDM1,RARG,RUNX1,SOX9,TFAP4,ZHX1</td><td valign="top" align="left" rowspan="1" colspan="1">CCNA2,CCND1,ERBB2,ERBB3,ESR1,FGFR3,HMGA2,HRAS,KRAS,MYC,NRAS</td><td valign="top" align="left" rowspan="1" colspan="1">CDKN1B,CDKN2A,E2F1,FOXO1,ITGB3,LATS2,MAP2K4,NF2,PLAGL1,PPP1CA,PRDM1,RECK,SMO,TP53,TP53INP1,TUSC2,UHRF2</td></tr></tbody></table><table-wrap-foot><p>TF: transcription factor; TSG: tumor suppressor gene.</p></table-wrap-foot></table-wrap></sec><sec><title>RB-related miRNAs with their targets</title><p>A total of 183 target genes of the DE-miRs were identified. By mapping them into the CTD database, 87 were considered to correlate with RB. Additionally, these genes were targeted by 14 DE-miRs, including <italic>hsa-miR-373</italic>, <italic>hsa-miR-125b</italic>, <italic>hsa-miR-20a</italic>, <italic>hsa-miR-145</italic>, <italic>hsa-let-7</italic> (<italic>a</italic>, <italic>b</italic>, <italic>c</italic>), <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, <italic>hsa-miR-182</italic>, <italic>hsa-miR-99a</italic>, <italic>hsa-miR-183</italic>, <italic>hsa-miR-451</italic>, and <italic>hsa-miR-181a</italic>, which completely distinguished the RB samples from the healthy samples (<xref ref-type="table" rid="t3">Table 3</xref> and <xref ref-type="fig" rid="f4">Figure 4</xref>). Therefore, these miRNAs might be used as the biomarkers of RB.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Retinoblastoma-related miRNAs and their target genes.</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="340" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>miRNAs</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Target genes</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-373<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GPSM2, KIF23, GLTP, LATS2, TFAP4, GBP3, PRC1, LMNB1, RNF149, INSIG2, TEX30, CYB5R4, RPIA, PBK, STK4, KDM1B, CENPF, TBC1D2, ARHGEF3, CD83<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-125b<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ID2, CASP6, ADAMTS1, NTRK3, ID3, JARID2, CBX7, UGT2B17, ELAVL1, BAK1, EIF4EBP1, TENM2, E2F3, MAN1A1, KRT19, TP53INP1, TP53, CDC25A, CDKN2A, CDK6, SMO, BMPR1B, CYP1A1, CASP7, BBC3, CBLN2, UBE2I, IL1RN, B3GALT4, CDC25C, ERBB3, ERBB2, PIGR<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-20a<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">BCL2L11, CCND1, BMPR2, RUNX1, E2F1, MAP3K12<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-let-7b<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">CDC25A, CDK6, CCND1, HMGA2, KRT19<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-145<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">FSCN1, SOX9, IGF1R, RTKN, CCNA2, MYC, PPP3CA<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-let-7a<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">NF2, SMOX, KRAS, ITGB3, CASP3, HMGA2, HRAS, NRAS<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-182<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">MITF, IGF1R, RARG<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-99a<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">MTOR, IGF1R, FGFR3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-25<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">MAP2K4, BCL2L11<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-18a<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">CTGF, BCL2L11, ESR1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-181a<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">CDKN1B, ESR1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-183<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">FOXO1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-let-7c<hr/></td><td valign="middle" align="left" rowspan="1" colspan="1">MYC, HMGA2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">hsa-miR-451</td><td valign="middle" align="left" rowspan="1" colspan="1">ABCB1</td></tr></tbody></table></table-wrap><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Clustering analysis of the 14 differentially expressed miRNAs in two types of samples. Healthy 1&#x02013;3 denote the healthy retina samples, and Rb 1&#x02013;3 denote the retinoblastoma samples. The values on the edges of the clusters are p values (%). The red values are approximately unbiased (au) p values, and the green values are bootstrap probability (bp) values. Clusters with au larger than 95% are highlighted by rectangles, which are strongly supported by data.</p></caption><graphic xlink:href="mv-v21-1307-f4"/></fig></sec><sec><title>The correlation network of the DE-miRs</title><p>The correlation network showing the common target genes of the DE-miRs is shown in <xref ref-type="fig" rid="f5">Figure 5</xref>. As presented in this network, the predominant correlated miRNA interactions were <italic>hsa-let-7b</italic> and <italic>hsa-miR-125b</italic> (the common target genes were <italic>CDC25A</italic>, <italic>LIN28A</italic>, and <italic>CDK6</italic>); and <italic>hsa-miR-18a</italic>, <italic>hsa-miR-20a</italic>, and <italic>hsa-miR-25</italic> (the common target gene was <italic>BCL2L11</italic>).</p><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>Correlation network of the differentially expressed miRNAs. The blue circle represents genes, and the red rectangle represents upregulated miRNAs, while the green rectangle represents downregulated miRNAs. The arrow denotes the direct interaction between miRNA and its target gene.</p></caption><graphic xlink:href="mv-v21-1307-f5"/></fig></sec><sec><title>Validation of miRNA expression</title><p>As shown in <xref ref-type="table" rid="t4">Table 4</xref>, in comparison with the GSE7072 profile, ten miRNAs, including six identified DE-miRs (out of the 24 DE-miRs), were also differentially expressed in the RB samples in the GSE41321 profile. Notably, the expression of three DE-miRs, including upregulated <italic>hsa-miR-18a</italic> and downregulated <italic>hsa-let-7b</italic> and <italic>hsa-let-7c</italic>, was in accordance with our results.</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>miRNA (10 DE-miRs) expression comparison between expression profiles of GSE41321 and GSE7072.</title></caption><table frame="hsides" rules="groups"><col width="79" span="1"/><col width="86" span="1"/><col width="58" span="1"/><col width="86" span="1"/><col width="62" span="1"/><thead><tr><th rowspan="2" valign="top" align="justify" scope="col" colspan="1"><bold>miRNAs</bold></th><th valign="middle" colspan="2" align="center" scope="colgroup" rowspan="1"><bold>GSE41321</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>GSE7072</bold><hr/></th></tr><tr><th valign="middle" colspan="1" align="justify" scope="colgroup" rowspan="1"><bold>Log FC</bold></th><th valign="middle" align="justify" scope="col" rowspan="1" colspan="1"><bold>P value</bold></th><th valign="middle" align="justify" scope="col" rowspan="1" colspan="1"><bold>Log FC</bold></th><th valign="middle" align="justify" scope="col" rowspan="1" colspan="1"><bold>P value</bold></th></tr></thead><tbody><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-30d<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.699283069<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">8.34E-06<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;1.4135091<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">1.28E-02<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-18a<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.820197258<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">3.05E-05<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">1.486038867<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">3.38E-02<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-181a<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.872595328<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">1.01E-06<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;1.9342523<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">5.73E-04<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-183<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.561178808<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">1.26E-04<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;1.2667168<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">1.94E-02<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-182<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.95936798<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">5.54E-07<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;1.24761365<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">2.40E-02<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-125b<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.457144179<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">4.40E-04<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;2.520854685<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">3.56 E-04<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-191<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">&#x02212;0.483798552<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">1.04E-03<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;1.80388745<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">7.45E-03<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-miR-373<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">&#x02212;0.109119276<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">0.20<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">1.196955933<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">9.69E-03<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-let-7c<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">&#x02212;0.838050781<hr/></td><td valign="middle" align="justify" rowspan="1" colspan="1">6.21E-05<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;2.213052267<hr/></td><td valign="top" align="justify" rowspan="1" colspan="1">3.67E-03<hr/></td></tr><tr><td valign="middle" align="justify" scope="row" rowspan="1" colspan="1">hsa-let-7b</td><td valign="middle" align="justify" rowspan="1" colspan="1">&#x02212;0.704607286</td><td valign="middle" align="justify" rowspan="1" colspan="1">4.49E-05</td><td valign="top" align="justify" rowspan="1" colspan="1">&#x02212;3.044672233</td><td valign="top" align="justify" rowspan="1" colspan="1">9.35E-05</td></tr></tbody></table><table-wrap-foot><p>DE-miRs: differentially expressed miRNAs (between retinoblastoma and control samples); FC: fold change; miRNAs with positive value of Log FC represent upregulated miRNAs in retinoblastoma samples; while with negative value indicate downregulated miRNAs in retinoblastoma samples.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>RB is a primary pediatric cancer of the retina. In this study, we performed a series of analyses using powerful bioinformatics methods and finally identified a total of 24 DE-miRs between the RB and healthy retina samples. Interestingly, nine DE-miRs, including <italic>let-7c</italic>, <italic>hsa-miR-182</italic>, <italic>hsa-miR-99b</italic>, <italic>hsa-miR-125b</italic>, <italic>hsa-miR-191</italic>, <italic>hsa-miR-181a</italic>, <italic>hsa-miR-17&#x02013;5p</italic>, <italic>hsa-miR-373</italic>, and <italic>let-7b</italic>, were consistent with work performed by Huang et al. [<xref rid="r17" ref-type="bibr">17</xref>], who identified 25 DE-miRs in RB samples. The potential reasons for the other different miRNAs might be due to different selection criteria. As Huang et al. aimed to discover the interacting miRNA&#x02013;target relationships using paired miRNA and mRNA expression profiles, they might have applied a different criterion to choose the interacting miRNA target. In contrast, this study used their miRNA expression profile and predicted the corresponding targets based on the miRecords and MirWalk databases. However, the nine common DE-miRs suggest that our findings are also reliable.</p><p>Interestingly, the expression of three DE-miRs was consistent with that in another profile, GSE41321, including <italic>hsa-miR-18a</italic>, <italic>hsa-let-7b</italic>, and <italic>hsa-let-7c</italic>. Although the GSE41321 samples are collected from serum, Beta et al. confirmed that a set of 33 deregulated miRNAs, such as the upregulated <italic>hsa-miR-18a</italic> and the downregulated <italic>hsa-let-7c</italic>, are also found in RB tumor samples in comparison with the tumor RB miRNA profiles [<xref rid="r27" ref-type="bibr">27</xref>]. This finding indicates several miRNAs in serum might have the same expression patterns as in tumors and could be used as potential biomarkers for the prognosis and prediction of RB development. Enrichment analysis indicated that the target genes of the present identified DE-miRs were mainly involved in cancer-related pathways and the cell cycle pathway. Among these DE-miRs, <italic>hsa-miR-373</italic>, <italic>hsa-miR-125b</italic>, and <italic>hsa-miR-181a</italic> were highlighted with multiple target genes in the integrated miRNA&#x02013;target regulatory network; meanwhile, 14 DE-miRs, such as <italic>hsa-miR-373</italic>, <italic>hsa-miR-125b</italic>, <italic>hsa-miR-20a</italic>, <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-let-7</italic> (<italic>a, b, c</italic>) were shown to distinguish RB from healthy samples. Notably, <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-miR-20a</italic> shared the common target gene <italic>BCL2L11</italic>; <italic>hsa-let-7b</italic> and <italic>hsa-miR-125b</italic> targeted three genes, <italic>CDC25A</italic>, <italic>CDK6</italic>, and <italic>LIN28A</italic>.</p><p><italic>MiR-373</italic> is implicated in numerous cancer events. Previously, <italic>miR-373&#x02013;3</italic> was considered the signature of human embryonic stem cells [<xref rid="r29" ref-type="bibr">29</xref>]. In prostate cancer, in vitro experiments showed that <italic>miR-373</italic> stimulates cell migration and invasion [<xref rid="r30" ref-type="bibr">30</xref>]. Additionally, the role of <italic>miR-373</italic> as an activator in tumor invasion and metastasis has been verified in vivo and in vitro by inhibiting the expression of <italic>CD44</italic> [<xref rid="r31" ref-type="bibr">31</xref>]. Furthermore, <italic>miR-373</italic> is proproliferative in human epithelial ovarian cancer cells [<xref rid="r32" ref-type="bibr">32</xref>]. Several studies corroborated that <italic>miR-373</italic> is highly expressed in RB tumors, in comparison with healthy retinas [<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r33" ref-type="bibr">33</xref>], which is consistent with our result. Notably, our enrichment analysis showed that the targets of <italic>hsa-miR-373</italic> were tightly correlated with a cohort of cancer-related pathways, providing potent evidence that <italic>hsa-miR-373</italic> might function in RB tumors as in other cancers. Given that RB has a tendency toward local invasion and metastasis [<xref rid="r34" ref-type="bibr">34</xref>], it might be speculated that <italic>miR-373</italic> might also play remarkable roles in the regulation of RB invasion and metastasis.</p><p>Defects in the gene <italic>RB1</italic>, which serves as a negative regulator of cell cycle and a tumor suppressor, are known to be the main cause for the genesis of RB in children. A cluster of miRNAs acts as regulators in cell proliferation, apoptosis, and senescence via interfering with the p53 pathway or <italic>RB1</italic>/<italic>E2F</italic> function [<xref rid="r35" ref-type="bibr">35</xref>,<xref rid="r36" ref-type="bibr">36</xref>]. <italic>MiR-125b</italic> has been confirmed to function as a tumor suppressor by inducing cellular senescence in cutaneous malignant melanoma [<xref rid="r37" ref-type="bibr">37</xref>]. Notably, <italic>miR-125b</italic> is closely related to the p53 pathway in colorectal cancer [<xref rid="r38" ref-type="bibr">38</xref>]. These collectively provide a clue that <italic>miR-125b</italic> might also be involved in the regulation of proliferation during RB development via the p53-mediated pathway. In human U251 glioma stem cells, the overexpression of <italic>miR-125b</italic> is highly correlated with the decreased expression of <italic>CDK6</italic> and <italic>CDC25A</italic>, two cell cycle&#x02013;mediated genes [<xref rid="r39" ref-type="bibr">39</xref>]. Moreover, <italic>CDK6</italic> and <italic>CDC25A</italic> are mediated by <italic>miR-125b</italic> in other types of cancer, such as breast cancer [<xref rid="r40" ref-type="bibr">40</xref>] and bladder cancer [<xref rid="r41" ref-type="bibr">41</xref>]. The oncogene <italic>LIN28B</italic> has been demonstrated to be the downstream of <italic>miR-125b</italic>, and by binding to the 3&#x02032; untranslated region (UTR) region of <italic>LIN28B</italic>, <italic>miR-125b</italic> successfully inhibited the cell growth in hepatocellular carcinoma [<xref rid="r42" ref-type="bibr">42</xref>]. The regulatory relationships between <italic>hsa-let-7b</italic> and the target <italic>CDC25A</italic> have been well established in RB cells [<xref rid="r17" ref-type="bibr">17</xref>]. Additionally, <italic>let-7</italic> is suggested to indirectly regulate the cell cycle by suppressing <italic>IMP1</italic>, an essential gene for <italic>CDC25A</italic> and <italic>CDK6</italic> expression [<xref rid="r43" ref-type="bibr">43</xref>]. Furthermore, <italic>let-7</italic> could also downregulate the mRNA of <italic>LIN28B</italic> during neural stem cell commitment [<xref rid="r44" ref-type="bibr">44</xref>]. Interestingly, our results showed that <italic>CDK6</italic>, <italic>CDC25A</italic>, and <italic>LIN28A</italic>, the paralog of <italic>LIN28B</italic>, were all targeted by <italic>miR-125b</italic> and <italic>hsa-let-7b</italic>, indicating these two miRNAs might play crucial roles in the development of RB, via the coregulation of the three cell cycle&#x02013;related target genes.</p><p><italic>Hsa-miR-181b</italic> and <italic>hsa-miR-181a</italic> are downregulated in human gliomas and have been implicated as tumor suppressors by inhibiting glioma proliferation [<xref rid="r45" ref-type="bibr">45</xref>]. In RB cells, elevated <italic>miR-181b</italic> has been verified to play a positive role in RB cell proliferation under hypoxic conditions [<xref rid="r46" ref-type="bibr">46</xref>]. Considering that RB is a cancer of the nervous system and <italic>miR-181b</italic> is dysregulated in the central nervous system disease schizophrenia, <italic>miR-181b</italic> has been suggested to be involved in the genesis of RB [<xref rid="r46" ref-type="bibr">46</xref>]. In addition, <italic>miR-181a</italic>, along with <italic>miR-183</italic> and <italic>miR-124</italic>, presents the most frequent alterations among the miRNAs differentially expressed in RB [<xref rid="r47" ref-type="bibr">47</xref>]. The <italic>CDKN1B</italic> gene, an important regulator of the cell cycle, has been demonstrated as the target of <italic>miR-221</italic> and <italic>miR-222</italic> in the development of thyroid cancer [<xref rid="r48" ref-type="bibr">48</xref>]. Our results indicated that <italic>hsa-miR-181a</italic> was a crucial miRNA of RB that targeted multiple genes, including <italic>CDKN1B</italic>, which was predicted to be a TSG enriching in the cell cycle pathway. Therefore, it might be inferred that <italic>hsa-miR-181a</italic> might act as an important regulator in RB progression via the <italic>CDKN1B</italic>-mediated cell cycle pathway.</p><p>The <italic>BCL2L11</italic> encoded protein belongs to the BCL-2 protein family, which act as important apoptotic activators in extensive cellular activities [<xref rid="r49" ref-type="bibr">49</xref>]. Transforming growth factor-&#x003b2; (TGF-&#x003b2;) is a cytokine that has a significant role in the apoptosis of gastrointestinal cells. <italic>miR-25</italic> overexpression decreases TGF&#x003b2;-induced apoptosis by interfering with the synthesis of <italic>BCL2L11</italic> in gastric cancer [<xref rid="r50" ref-type="bibr">50</xref>]. Additionally, <italic>miR-20a</italic> has also been reported to target <italic>BCL2L1</italic>, while <italic>miR-18a</italic> could target <italic>Smad2</italic> and <italic>Smad4</italic> in the TGF-&#x003b2; signaling pathway, in which the activation of TGF-&#x003b2; is partly regulated by <italic>BCL2L11</italic> [<xref rid="r51" ref-type="bibr">51</xref>]. In the present study, <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-miR-20a</italic> simultaneously targeted <italic>BCL2L1</italic> in the correlation network of the DE-miRs, suggesting that the three miRNAs might have vital roles in the progression of RB by coregulating <italic>BCL2L1</italic>. However, the potential interactions between these miRNAs must be further elucidated.</p><p>The present study has several limitations. First, the sample size was small because only three RB samples and three healthy samples were contained in the data sets. Moreover, although we used another data set to validate the miRNA expression, the expression of only three miRNAs was confirmed. Experimental validation of miRNA expression and miRNA&#x02013;target regulation was lacking, which will be considered in follow-up studies.</p><p>In conclusion, a set of critical miRNA signatures was identified in RB progression. Among them, <italic>hsa-miR-373</italic> might play significant roles in the regulation of RB invasion and metastasis, <italic>hsa-miR-125b</italic> and <italic>hsa-let-7b</italic> might exert their roles as tumor suppressors via the coregulation of <italic>CDK6</italic>, <italic>CDC25A</italic>, and <italic>LIN28A</italic>, which all mediated the cell cycle pathway, and <italic>hsa-miR-181a</italic> might involve in the <italic>CDKN1B</italic>-regulated cell cycle pathway. Additionally, <italic>hsa-miR-25</italic>, <italic>hsa-miR-18a</italic>, and <italic>hsa-miR-20a</italic> might affect the progression of RB by the coregulation of <italic>BCL2L1</italic>. However, additional experimental studies are needed to confirm these results.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Hubei Provincial Natural Science Foundation of China (No. 2014CFB366).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JR</given-names></name><name><surname>Tucker</surname><given-names>MA</given-names></name><name><surname>Kleinerman</surname><given-names>RA</given-names></name><name><surname>Devesa</surname><given-names>SS</given-names></name></person-group><article-title>Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program.</article-title><source>JAMA Ophthalmol</source><year>2014</year><volume>132</volume><fpage>478</fpage><lpage>83</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=24577366&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">24577366</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waddell</surname><given-names>KM</given-names></name><name><surname>Kagame</surname><given-names>K</given-names></name><name><surname>Ndamira</surname><given-names>A</given-names></name><name><surname>Twinamasiko</surname><given-names>A</given-names></name><name><surname>Picton</surname><given-names>SV</given-names></name><name><surname>Simmons</surname><given-names>IG</given-names></name><name><surname>Johnston</surname><given-names>WT</given-names></name><name><surname>Newton</surname><given-names>R</given-names></name></person-group><article-title>Clinical features and survival among children with retinoblastoma in Uganda.</article-title><source>Br J Ophthalmol</source><year>2015</year><volume>99</volume><fpage>387</fpage><lpage>90</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=25217695&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">25217695</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Woo</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name></person-group><article-title>Incidence of Retinoblastoma and Survival Rate of Retinoblastoma Patients in Korea Using the Korean National Cancer Registry Database (1993&#x02013;2010) Incidence and Survival of Retinoblastoma in Korea.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2014</year><volume>55</volume><fpage>2816</fpage><lpage>21</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=24692122&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">24692122</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S-Y</given-names></name><name><surname>Chen</surname><given-names>SC-C</given-names></name><name><surname>Tsai</surname><given-names>C-F</given-names></name><name><surname>Sheu</surname><given-names>S-M</given-names></name><name><surname>Yeh</surname><given-names>J-J</given-names></name><name><surname>Tsai</surname><given-names>C-B</given-names></name></person-group><article-title>Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998&#x02013;2011.</article-title><source>Br J Ophthalmol</source><year>2015</year><volume>xxx</volume><fpage>307211</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=26370121&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">26370121</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>EM</given-names></name><name><surname>Dyer</surname><given-names>M</given-names></name><name><surname>Guy</surname><given-names>R</given-names></name></person-group><article-title>Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.</article-title><source>Mini Rev Med Chem</source><year>2015</year><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=26202204&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">26202204</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chantada</surname><given-names>GL</given-names></name><name><surname>Qaddoumi</surname><given-names>I</given-names></name><name><surname>Canturk</surname><given-names>S</given-names></name><name><surname>Khetan</surname><given-names>V</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Kimani</surname><given-names>K</given-names></name><name><surname>Yeniad</surname><given-names>B</given-names></name><name><surname>Sultan</surname><given-names>I</given-names></name><name><surname>Sitorus</surname><given-names>RS</given-names></name><name><surname>Tacyildiz</surname><given-names>N</given-names></name></person-group><article-title>Strategies to manage retinoblastoma in developing countries.</article-title><source>Pediatr Blood Cancer</source><year>2011</year><volume>56</volume><fpage>341</fpage><lpage>8</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21225909&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21225909</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Benavente</surname><given-names>CA</given-names></name><name><surname>McEvoy</surname><given-names>J</given-names></name><name><surname>Flores-Otero</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ulyanov</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>A novel retinoblastoma therapy from genomic and epigenetic analyses.</article-title><source>Nature</source><year>2012</year><volume>481</volume><fpage>329</fpage><lpage>34</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=22237022&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">22237022</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B-Q</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>Y-D</given-names></name></person-group><article-title>Identification of retinoblastoma related genes with shortest path in a protein&#x02013;protein interaction network.</article-title><source>Biochimie</source><year>2012</year><volume>94</volume><fpage>1910</fpage><lpage>7</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=22627383&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">22627383</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gayral</surname><given-names>M</given-names></name><name><surname>Jo</surname><given-names>S</given-names></name><name><surname>Hanoun</surname><given-names>N</given-names></name><name><surname>Vignolle-Vidoni</surname><given-names>A</given-names></name><name><surname>Lulka</surname><given-names>H</given-names></name><name><surname>Delpu</surname><given-names>Y</given-names></name><name><surname>Meulle</surname><given-names>A</given-names></name><name><surname>Dufresne</surname><given-names>M</given-names></name><name><surname>Humeau</surname><given-names>M</given-names></name><name><surname>du Rieu</surname><given-names>MC</given-names></name></person-group><article-title>MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><fpage>11199</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=25170204&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">25170204</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannini</surname><given-names>I</given-names></name><name><surname>Fanini</surname><given-names>F</given-names></name><name><surname>Fabbri</surname><given-names>M</given-names></name></person-group><article-title>MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis.</article-title><source>Clin Biochem</source><year>2013</year><volume>46</volume><fpage>918</fpage><lpage>25</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=23396164&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">23396164</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>YS</given-names></name><name><surname>Sun</surname><given-names>YF</given-names></name><name><surname>Miao</surname><given-names>LX</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>YS</given-names></name><name><surname>Liu</surname><given-names>HY</given-names></name><name><surname>Liu</surname><given-names>QL</given-names></name></person-group><article-title>Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma.</article-title><source>Biomed Rep</source><year>2014</year><volume>2</volume><fpage>424</fpage><lpage>8</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=24748987&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">24748987</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J-J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>N</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>JQ</given-names></name><name><surname>Lin</surname><given-names>J-Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title>Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis.</article-title><source>Childs Nerv Syst</source><year>2009</year><volume>25</volume><fpage>13</fpage><lpage>20</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18818933&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18818933</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group><article-title>MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9.</article-title><source>FEBS Lett</source><year>2015</year><volume>589</volume><fpage>645</fpage><lpage>50</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=25647033&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">25647033</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Bryar</surname><given-names>P</given-names></name><name><surname>Mets</surname><given-names>M</given-names></name><name><surname>Weinstein</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Vanin</surname><given-names>EF</given-names></name><name><surname>Scholtens</surname><given-names>D</given-names></name><name><surname>Costa</surname><given-names>FF</given-names></name><name><surname>Soares</surname><given-names>MB</given-names></name></person-group><article-title>Differentially expressed miRNAs in retinoblastoma.</article-title><source>Gene</source><year>2013</year><volume>512</volume><fpage>294</fpage><lpage>9</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=23103829&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">23103829</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conkrite</surname><given-names>K</given-names></name><name><surname>Sundby</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>S</given-names></name><name><surname>Thomson</surname><given-names>JM</given-names></name><name><surname>Mu</surname><given-names>D</given-names></name><name><surname>Hammond</surname><given-names>SM</given-names></name><name><surname>MacPherson</surname><given-names>D</given-names></name></person-group><article-title>miR-17&#x0223c; 92 cooperates with RB pathway mutations to promote retinoblastoma.</article-title><source>Genes Dev</source><year>2011</year><volume>25</volume><fpage>1734</fpage><lpage>45</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21816922&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21816922</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guha</surname><given-names>N</given-names></name><name><surname>Deepak</surname><given-names>S</given-names></name><name><surname>Lateef</surname><given-names>S</given-names></name><name><surname>Padmanabhan</surname><given-names>A</given-names></name><name><surname>Gundimeda</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Mallipatna</surname><given-names>A</given-names></name><name><surname>Babu</surname><given-names>VS</given-names></name></person-group><article-title>A Multi-omics Approach to Identify Biomarkers of Clinically Advanced Retinoblastoma for Diagnostics and Therapeutic Applications.</article-title><source>FASEB J</source><year>2015</year><volume>29</volume><fpage>417</fpage></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>JC</given-names></name><name><surname>Babak</surname><given-names>T</given-names></name><name><surname>Corson</surname><given-names>TW</given-names></name><name><surname>Chua</surname><given-names>G</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Gallie</surname><given-names>BL</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name><name><surname>Blencowe</surname><given-names>BJ</given-names></name><name><surname>Frey</surname><given-names>BJ</given-names></name><name><surname>Morris</surname><given-names>QD</given-names></name></person-group><article-title>Using expression profiling data to identify human microRNA targets.</article-title><source>Nat Methods</source><year>2007</year><volume>4</volume><fpage>1045</fpage><lpage>9</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18026111&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18026111</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolstad</surname><given-names>BM</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>&#x000c5;strand</surname><given-names>M</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name></person-group><article-title>A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>185</fpage><lpage>93</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=12538238&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">12538238</pub-id></element-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="book">Smyth GK. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor: Springer; 2005. p. 397&#x02013;420.</mixed-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>F</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><article-title>miRecords: an integrated resource for microRNA&#x02013;target interactions.</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><fpage>D105</fpage><lpage>10</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18996891&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18996891</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dweep</surname><given-names>H</given-names></name><name><surname>Sticht</surname><given-names>C</given-names></name><name><surname>Pandey</surname><given-names>P</given-names></name><name><surname>Gretz</surname><given-names>N</given-names></name></person-group><article-title>miRWalk&#x02013;database: prediction of possible miRNA binding sites by &#x0201c;walking&#x0201d; the genes of three genomes.</article-title><source>J Biomed Inform</source><year>2011</year><volume>44</volume><fpage>839</fpage><lpage>47</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21605702&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21605702</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Hosack</surname><given-names>DA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><article-title>DAVID: database for annotation, visualization, and integrated discovery.</article-title><source>Genome Biol</source><year>2003</year><volume>4</volume><fpage>3</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=12734009&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">12734009</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matys</surname><given-names>V</given-names></name><name><surname>Kel-Margoulis</surname><given-names>OV</given-names></name><name><surname>Fricke</surname><given-names>E</given-names></name><name><surname>Liebich</surname><given-names>I</given-names></name><name><surname>Land</surname><given-names>S</given-names></name><name><surname>Barre-Dirrie</surname><given-names>A</given-names></name><name><surname>Reuter</surname><given-names>I</given-names></name><name><surname>Chekmenev</surname><given-names>D</given-names></name><name><surname>Krull</surname><given-names>M</given-names></name><name><surname>Hornischer</surname><given-names>K</given-names></name></person-group><article-title>TRANSFAC&#x000ae; and its module TRANSCompel&#x000ae;: transcriptional gene regulation in eukaryotes.</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D108</fpage><lpage>10</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=16381825&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">16381825</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>TSGene: a web resource for tumor suppressor genes.</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>D970</fpage><lpage>76</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=23066107&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">23066107</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiegers</surname><given-names>TC</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Cohen</surname><given-names>KB</given-names></name><name><surname>Hirschman</surname><given-names>L</given-names></name><name><surname>Mattingly</surname><given-names>CJ</given-names></name></person-group><article-title>Text mining and manual curation of chemical-gene-disease networks for the comparative toxicogenomics database (CTD).</article-title><source>BMC Bioinformatics</source><year>2009</year><volume>10</volume><fpage>326</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=19814812&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">19814812</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Shimodaira</surname><given-names>H</given-names></name></person-group><article-title>Pvclust: an R package for assessing the uncertainty in hierarchical clustering.</article-title><source>Bioinformatics</source><year>2006</year><volume>22</volume><fpage>1540</fpage><lpage>2</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=16595560&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">16595560</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beta</surname><given-names>M</given-names></name><name><surname>Venkatesan</surname><given-names>N</given-names></name><name><surname>Vasudevan</surname><given-names>M</given-names></name><name><surname>Vetrivel</surname><given-names>U</given-names></name><name><surname>Khetan</surname><given-names>V</given-names></name><name><surname>Krishnakumar</surname><given-names>S</given-names></name></person-group><article-title>Identification and insilico analysis of retinoblastoma serum microRNA profile and gene targets towards prediction of novel serum biomarkers.</article-title><source>Bioinform Biol Insights</source><year>2013</year><volume>7</volume><fpage>21</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=23400111&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">23400111</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudy</surname><given-names>J</given-names></name><name><surname>Valafar</surname><given-names>F</given-names></name></person-group><article-title>Empirical comparison of cross-platform normalization methods for gene expression data.</article-title><source>BMC Bioinformatics</source><year>2011</year><volume>12</volume><fpage>467</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=22151536&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">22151536</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Marincola</surname><given-names>FM</given-names></name><name><surname>Stroncek</surname><given-names>DF</given-names></name></person-group><article-title>MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells.</article-title><source>J Transl Med</source><year>2009</year><volume>7</volume><fpage>20</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=19309508&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">19309508</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Handorean</surname><given-names>AM</given-names></name><name><surname>Iczkowski</surname><given-names>KA</given-names></name></person-group><article-title>MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro.</article-title><source>Int J Clin Exp Pathol</source><year>2009</year><volume>2</volume><fpage>361</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=19158933&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">19158933</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Gumireddy</surname><given-names>K</given-names></name><name><surname>Schrier</surname><given-names>M</given-names></name><name><surname>Le Sage</surname><given-names>C</given-names></name><name><surname>Nagel</surname><given-names>R</given-names></name><name><surname>Nair</surname><given-names>S</given-names></name><name><surname>Egan</surname><given-names>DA</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Klein-Szanto</surname><given-names>AJ</given-names></name></person-group><article-title>The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><fpage>202</fpage><lpage>10</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18193036&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18193036</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Miyazawa</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group><article-title>Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.</article-title><source>Int J Oncol</source><year>2013</year><volume>42</volume><fpage>1875</fpage><lpage>82</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=23588298&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">23588298</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>AH</given-names></name><name><surname>Vargas</surname><given-names>FR</given-names></name><name><surname>Lemos</surname><given-names>B</given-names></name></person-group><article-title>More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma.</article-title><source>Front Genet</source><year>2012</year><volume>3</volume><fpage>284</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=23233862&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">23233862</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Hosaka</surname><given-names>K</given-names></name><name><surname>Jensen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zhuang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model.</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>10351</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=26169357&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">26169357</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farh</surname><given-names>KK-H</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Jan</surname><given-names>C</given-names></name><name><surname>Lewis</surname><given-names>BP</given-names></name><name><surname>Johnston</surname><given-names>WK</given-names></name><name><surname>Lim</surname><given-names>LP</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group><article-title>The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.</article-title><source>Science</source><year>2005</year><volume>310</volume><fpage>1817</fpage><lpage>21</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=16308420&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">16308420</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name></person-group><article-title>microRNAs: small molecules with big roles&#x02013;C. elegans to human cancer.</article-title><source>Biol Cell</source><year>2008</year><volume>100</volume><fpage>71</fpage><lpage>81</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18199046&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18199046</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyholm</surname><given-names>AM</given-names></name><name><surname>Lerche</surname><given-names>CM</given-names></name><name><surname>Manf&#x000e9;</surname><given-names>V</given-names></name><name><surname>Biskup</surname><given-names>E</given-names></name><name><surname>Johansen</surname><given-names>P</given-names></name><name><surname>Morling</surname><given-names>N</given-names></name><name><surname>Thomsen</surname><given-names>BM</given-names></name><name><surname>Glud</surname><given-names>M</given-names></name><name><surname>Gniadecki</surname><given-names>R</given-names></name></person-group><article-title>miR-125b induces cellular senescence in malignant melanoma.</article-title><source>BMC Dermatol</source><year>2014</year><volume>14</volume><fpage>8</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=24762088&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">24762088</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>N</given-names></name><name><surname>Yokobori</surname><given-names>T</given-names></name><name><surname>Mimori</surname><given-names>K</given-names></name><name><surname>Sudo</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>H</given-names></name><name><surname>Doki</surname><given-names>Y</given-names></name><name><surname>Kuwano</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name></person-group><article-title>MicroRNA miR-125b is a prognostic marker in human colorectal cancer.</article-title><source>Int J Oncol</source><year>2011</year><volume>38</volume><fpage>1437</fpage><lpage>43</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21399871&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21399871</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>You</surname><given-names>Y</given-names></name></person-group><article-title>MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation.</article-title><source>Brain Res</source><year>2010</year><volume>1312</volume><fpage>120</fpage><lpage>6</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=19948152&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">19948152</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>L-X</given-names></name><name><surname>Wu</surname><given-names>Q-N</given-names></name><name><surname>Du</surname><given-names>Z-M</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>D-Z</given-names></name><name><surname>Huang</surname><given-names>M-Y</given-names></name><name><surname>Hou</surname><given-names>J-H</given-names></name><name><surname>Wu</surname><given-names>Q-L</given-names></name><name><surname>Zeng</surname><given-names>M-S</given-names></name></person-group><article-title>miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.</article-title><source>Cancer Res</source><year>2011</year><volume>71</volume><fpage>3552</fpage><lpage>62</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21444677&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21444677</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>Y-W</given-names></name><name><surname>Mao</surname><given-names>Y-Q</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y-F</given-names></name><name><surname>Zheng</surname><given-names>X-Y</given-names></name><name><surname>Xie</surname><given-names>L-P</given-names></name></person-group><article-title>MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.</article-title><source>Cancer Lett</source><year>2012</year><volume>320</volume><fpage>40</fpage><lpage>7</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=22266187&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">22266187</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>CM</given-names></name><name><surname>Ying</surname><given-names>Q</given-names></name><name><surname>Fan</surname><given-names>DNY</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>M</given-names></name></person-group><article-title>MicroRNA&#x02010;125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.</article-title><source>Hepatology</source><year>2010</year><volume>52</volume><fpage>1731</fpage><lpage>40</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=20827722&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">20827722</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barh</surname><given-names>D</given-names></name></person-group><article-title>Let-7 replacement therapy: applicability in cancer.</article-title><source>Cancer Ther</source><year>2008</year><volume>6</volume><fpage>969</fpage><lpage>84</lpage></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybak</surname><given-names>A</given-names></name><name><surname>Fuchs</surname><given-names>H</given-names></name><name><surname>Smirnova</surname><given-names>L</given-names></name><name><surname>Brandt</surname><given-names>C</given-names></name><name><surname>Pohl</surname><given-names>EE</given-names></name><name><surname>Nitsch</surname><given-names>R</given-names></name><name><surname>Wulczyn</surname><given-names>FG</given-names></name></person-group><article-title>A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment.</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><fpage>987</fpage><lpage>93</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18604195&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18604195</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>You</surname><given-names>Y</given-names></name></person-group><article-title>hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.</article-title><source>Brain Res</source><year>2008</year><volume>1236</volume><fpage>185</fpage><lpage>93</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18710654&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18710654</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Jia</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>G</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name></person-group><article-title>Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.</article-title><source>Int J Oncol</source><year>2011</year><volume>38</volume><fpage>1385</fpage><lpage>93</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21373755&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21373755</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Teng</surname><given-names>Y</given-names></name></person-group><article-title>MicroRNA&#x02010;183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6.</article-title><source>FEBS J</source><year>2014</year><volume>281</volume><fpage>1355</fpage><lpage>65</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=24289859&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">24289859</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marini</surname><given-names>F</given-names></name><name><surname>Luzi</surname><given-names>E</given-names></name><name><surname>Brandi</surname><given-names>ML</given-names></name></person-group><article-title>MicroRNA Role in Thyroid Cancer Development.</article-title><source>J Thyroid Res</source><year>2011</year><volume>2011</volume><fpage>407123</fpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=21687652&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">21687652</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michelle</surname><given-names>L</given-names></name><name><surname>Cloutier</surname><given-names>A</given-names></name><name><surname>Toutant</surname><given-names>J</given-names></name><name><surname>Shkreta</surname><given-names>L</given-names></name><name><surname>Thibault</surname><given-names>P</given-names></name><name><surname>Durand</surname><given-names>M</given-names></name><name><surname>Garneau</surname><given-names>D</given-names></name><name><surname>Gendron</surname><given-names>D</given-names></name><name><surname>Lapointe</surname><given-names>E</given-names></name><name><surname>Couture</surname><given-names>S</given-names></name></person-group><article-title>Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators.</article-title><source>Mol Cell Biol</source><year>2012</year><volume>32</volume><fpage>954</fpage><lpage>67</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=22203037&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">22203037</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrocca</surname><given-names>F</given-names></name><name><surname>Visone</surname><given-names>R</given-names></name><name><surname>Onelli</surname><given-names>MR</given-names></name><name><surname>Shah</surname><given-names>MH</given-names></name><name><surname>Nicoloso</surname><given-names>MS</given-names></name><name><surname>De Martino</surname><given-names>I</given-names></name><name><surname>Iliopoulos</surname><given-names>D</given-names></name><name><surname>Pilozzi</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>C-G</given-names></name><name><surname>Negrini</surname><given-names>M</given-names></name></person-group><article-title>E2F1-regulated microRNAs impair TGF&#x003b2;-dependent cell-cycle arrest and apoptosis in gastric cancer.</article-title><source>Cancer Cell</source><year>2008</year><volume>13</volume><fpage>272</fpage><lpage>86</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=18328430&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">18328430</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogilyansky</surname><given-names>E</given-names></name><name><surname>Rigoutsos</surname><given-names>I</given-names></name></person-group><article-title>The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease.</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>1603</fpage><lpage>14</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&#x00026;db=PubMed&#x00026;list_uids=24212931&#x00026;dopt=Abstract"/><pub-id pub-id-type="pmid">24212931</pub-id></element-citation></ref></ref-list></back></article>